AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC. — Form D/A
AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC. of ROCKVILLE, MD, a company, filed a Form D amendment with the SEC on 2025-12-22. The offering totals $10.0M, of which $310K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-12-22
- Form: D/A
- Accession: 0001586824-25-000005
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $310K
- Remaining: $9.7M
- Investors: 4
- Date of first sale: 2025-11-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-564282
Issuer
- Name: AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC.
- CIK: 0001586824
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 199 East Montgomery Ave., Suite 100, ROCKVILLE, MD, 20850
- Phone: 301-337-2100
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Jeffrey Adam Galvin | Director | Rockville, MD |
| William Drew Palin | Director | Rockville, MD |
| Barry Haden Wells | Director | Rockville, MD |
| Jeffrey Adam Galvin | Executive Officer | Rockville, MD |
| William Drew Palin | Executive Officer | Rockville, MD |
| Jeffrey Galvin | Director | Rockville, MD |
| Jeffrey Galvin | Executive Officer | Rockville, MD |
Other filings by this issuer (4)
More